QSC tirzepatide is a high-purity white powder with 99% purity, specifically designed for research purposes. This dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist has shown promising results in diabetes research studies.
The product is available in various packaging options to meet different research requirements. Our qsc tirzepatide demonstrates superior efficacy in glucose control and weight management compared to similar compounds, making it valuable for metabolic disorder research.
As a manufacturer, we offer customized packaging solutions including different vial sizes (2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 50mg) to accommodate various research needs. The product undergoes strict quality control testing to ensure consistency and reliability for research applications.
QSC tirzepatide has been shown to have greater affinity to GIP receptors than to GLP-1 receptors, producing more significant reductions in hyperglycemia compared to selective GLP-1 receptor agonists. This characteristic makes it particularly interesting for diabetes treatment research.
Important Note: This product is for research use only, not for human consumption. All orders must be for legitimate research purposes.